FDA Inspection
Corden Pharma Colorado, Inc.Corden Pharma Colorado, Inc. – FDA Inspection, Feb 6, 2019
Record Details
This FDA Inspection record concerns Corden Pharma Colorado, Inc., with an inspection on February 6, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · bacedf54-883d-41ba-9099-fd9c06083810
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1081516
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.160(a)Deviations from laboratory control requirements
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Corden Pharma Colorado, Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| November 14, 2025 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 30, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 12, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 28, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 11, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Corden Pharma Colorado, Inc.
- FDA Inspection 1294814 - 2025-11-14
- FDA Inspection 1052209 - 2018-03-30
- FDA Inspection 977464 - 2016-02-12
- FDA Inspection 840164 - 2013-06-28
- FDA Inspection 646639 - 2010-02-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.